Alexza
Pharmaceuticals Inc (NASDAQ:ALXA) will release the fourth quarter earnings
for 2007 on Monday, March 10.
A
pharmaceutical company, Alexza Pharmaceuticals is focused on the development
and commercialization of products to treat acute and intermittent
conditions. The Staccato system, Alexza’s
technology, vaporizes unformulated drugs to form a condensation aerosol to
allow rapid systematic drug delivery through lung inhalation. Company products include AZ-001 (Staccato
prochlorperazine), AZ-002 (Staccato alprazolam), AZ-004 (Staccato loxapine) and
AZ-003 (Staccato fentanyl).
For more
Earnings related events or to post your own events, visit: